Apocynin is a well-known NADPH-oxidase inhibitor, and there have been several studies on the therapeutic effect of apocynin in chronic inflammatory diseases such as atherosclerosis [7], rheumatoid arthritis [10], airway inflammation [9], stroke and IBD [12,13]. Here, FMO5 is linked to atherosclerosis.